newsfilter
← Latest News
PR Newswire·

VolitionRx Secures $2.0 Million in Funding

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has entered...